Medicine & Life Sciences
Africa South of the Sahara
10%
Alleles
15%
Animal Models
6%
Animals
7%
Anti-Bacterial Agents
5%
Anti-Infective Agents
8%
Antibodies
9%
Antigen Receptors
20%
Antigens
15%
Antimalarials
69%
Aotidae
38%
B-Lymphocyte Epitopes
13%
Basigin
13%
Biological Phenomena
12%
Biomarkers
16%
Blood Coagulation
5%
Carrier Proteins
18%
Cattle
27%
Central America
6%
Cercaria
14%
Chagas Disease
29%
Chemokines
12%
Clinical Trials
16%
Clostridiales
15%
Clostridium difficile
66%
Clostridium Infections
19%
Clostridium perfringens
33%
Clostridium tertium
49%
Coinfection
24%
Colombia
71%
Communicable Diseases
21%
Computer Simulation
9%
Costs and Cost Analysis
5%
Databases
14%
Delivery of Health Care
15%
Diarrhea
12%
DNA
6%
Domestication
6%
Drug Discovery
5%
Eggs
5%
Epidemiology
19%
Epitopes
21%
Erythrocytes
25%
Falciparum Malaria
8%
Feces
6%
Fibrinolysis
5%
Fluoroquinolones
9%
Foot-and-Mouth Disease
36%
Genes
23%
Genetic Variation
32%
Genome
53%
Genomics
30%
Glycophorins
11%
Haplotypes
17%
Health Facilities
26%
Health Services Needs and Demand
6%
Helminth DNA
18%
Histocompatibility Antigens Class II
12%
HLA Antigens
33%
Human papillomavirus 16
21%
Human papillomavirus 18
16%
Human papillomavirus 31
9%
Immune System
32%
Immunization
7%
In Vitro Techniques
14%
indolepropanol phosphate
13%
Infections
8%
Interleukin-12
5%
Interphase
9%
Larva
9%
Latin America
26%
Leishmania
9%
Ligands
17%
Liver
5%
Major Histocompatibility Complex
25%
Malaria
47%
Malaria Vaccines
11%
Membrane Potentials
24%
Merozoites
33%
Microbial Sensitivity Tests
8%
Neglected Diseases
15%
Occupational Groups
5%
Papillomavirus Infections
27%
Parasites
88%
Peptides
93%
Plasmodium
29%
Plasmodium falciparum
55%
Plasmodium vivax
75%
Platyhelminths
7%
Point-of-Care Testing
11%
Polymerase Chain Reaction
10%
Population
23%
Primates
34%
Protease Inhibitors
5%
Protein Binding
6%
Proteins
58%
Proteomics
7%
Public Health
14%
Reticulocytes
35%
RNA-Seq
11%
Safety
22%
Satellite DNA
37%
Schistosoma mansoni
18%
Schistosomiasis
29%
Sensitivity and Specificity
6%
Serine Proteinase Inhibitors
31%
Serogroup
18%
South America
6%
Southeastern Asia
6%
Strongyloides
38%
Strongyloides stercoralis
13%
Strongyloidiasis
36%
Subunit Vaccines
36%
Sulfonamides
10%
Synthetic Vaccines
36%
T-Lymphocyte Epitopes
5%
Taurine
29%
Theoretical Models
6%
Translational Medical Research
28%
Trypanosoma cruzi
29%
Urine
17%
Vaccination
11%
Vaccine Immunogenicity
34%
Vaccines
100%
varespladib methyl
6%
Virulence Factors
34%
Virus Internalization
6%
Agriculture & Biology
adjuvants
5%
animals
6%
antibodies
6%
antigens
6%
assays
7%
babesiosis
5%
cattle
5%
cells
5%
Clostridiales
14%
Clostridium difficile
47%
Clostridium paraputrificum
47%
Clostridium perfringens
33%
Clostridium tertium
47%
Colombia
27%
cryptosporidiosis
5%
diarrhea
6%
disease prevention
6%
foot-and-mouth disease
35%
Foot-and-mouth disease virus
6%
genes
5%
genome
13%
genomics
15%
health services
26%
human health
7%
immune response
7%
immunogenicity
29%
immunology
5%
infection
8%
Latin America
7%
microorganisms
8%
mixed infection
26%
molecular epidemiology
10%
Papillomaviridae
5%
pathogens
14%
peptides
19%
proteins
10%
public health
17%
serotypes
17%
sporulation
9%
subunit vaccines
6%
synthetic peptides
5%
synthetic vaccines
8%
therapeutics
9%
toxins
7%
vaccines
24%
virulence
19%
viruses
9%